Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...

KNOWLEDGE WEBINAR – TUESDAY, NOVEMBER 19TH - REGISTER HERE Do you face challenges with tedious manual annotation of tumor regions in whole slide images? Imagine a workflow with full-automatic biomarker quantification that eliminates...

Irish startup, Deciphex, has announced the closing €2.3m (approximately $2.59 million) in equity funding from a number of sources including support from Inova Personalized Health Accelerator in Virginia and GI Partners of Illinois, a group of...